Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes
- Conditions
- Diabetes Mellitus Type 2
- Registration Number
- NCT00659932
- Lead Sponsor
- Hunter and New England Health
- Brief Summary
This study was designed to assess whether a cognitive behavior therapy (CBT) program for diabetes clinic patients was acceptable, improved quality of life and produced measurable change in levels of depression, anxiety and stress.
- Detailed Description
Having co-morbid anxiety or depression makes it difficult to carry out the activities for diabetes selfcare. Psychological interventions have been shown to result in improvements in HbA1C and depression. Reports on psychosocial outcomes are conflicting and there are no studies of quality of life. Our diabetes outpatient population has a higher prevalence of anxiety and depression compared to the general public and this led to the development of a group CBT intervention designed to reduce anxiety as a co-morbidity of diabetes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
- Consenting attendees of the Hunter Area Diabetes Services RNH Diabetes Outpatient Clinic
-
Accessibility problems including:
- limited English
- developmental disability
- physical immobility
- geographical distance
- extreme age/frailty
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Hemoglobin A1C (HbA1C) 6 months
- Secondary Outcome Measures
Name Time Method Depression Anxiety Stress Scale (DASS) 6 months Diabetes Quality of Life (ADDQoL) 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Royal Newcastle Hospital
🇦🇺Newcastle, New South Wales, Australia
Royal Newcastle Hospital🇦🇺Newcastle, New South Wales, Australia